We are live on !
Find out more
Marshall Wace Portfolio holdings
AUM
$127B
Turnover
40.17%
1-Year Est. Return
46.06%
This Fund
S&P 500
This Quarter Est. Return
+26.15%
1 Year Est. Return
+46.06%
3 Year Est. Return
+142.12%
5 Year Est. Return
+190.33%
10 Year Est. Return
+787.47%
AUM
$127B
AUM Growth
+$26.3B
(+26%)
Cap. Flow
+$9.28B
Cap. Flow % of AUM
Cap. Flow %
7.32%
Top 10 Holdings %
Top 10 Hldgs %
37.66%
Holding
3,898
New
771
Increased
1,083
Reduced
1,182
Closed
795
Avg Time Held
Equity + Options
1
year
Top 10 Avg Time Held
Equity + Options
2.3
years
Top 20 Avg Time Held
Equity + Options
1.6
years
Avg Time Held Equity only
1
year
Top 10 Avg Time Held Equity only
2.4
years
Top 20 Avg Time Held Equity only
1.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.9B |
| 2 |
Costco
COST
|
+$907M |
| 3 |
AbbVie
ABBV
|
+$643M |
| 4 |
JPMorgan Chase
JPM
|
+$609M |
| 5 |
Bank of America
BAC
|
+$567M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Mercado Libre
MELI
|
+$528M |
| 3 |
Broadcom
AVGO
|
+$514M |
| 4 |
Sandisk
SNDK
|
+$507M |
| 5 |
Marvell Technology
MRVL
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.91% |
| 2 | Technology | 20.64% |
| 3 | Consumer Discretionary | 9.1% |
| 4 | Healthcare | 8.21% |
| 5 | Financials | 7.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2476
Vanguard FTSE Pacific ETF
VPL
$8.59B
| $525K | ﹤0.01% |
+4,534
| New | +$501K |
2026 Q2
0 quarters
|
|
2477
First Western Financial
MYFW
$301M
| $524K | ﹤0.01% |
+16,305
| New | +$464K |
2026 Q2
0 quarters
|
|
2478
EVI Industries
EVI
$269M
| $523K | ﹤0.01% |
+35,355
| New | +$651K |
2026 Q2
0 quarters
|
|
2479
Oatly Group
OTLY
$374M
| $522K | ﹤0.01% |
55,809
-15,723
| -22% | -$162K |
2026 Q1
1 quarter
|
|
2480
Community Healthcare Trust
CHCT
$364M
| $521K | ﹤0.01% |
+28,502
| New | +$495K |
2026 Q2
0 quarters
|
|
2481
Arcturus Therapeutics
ARCT
$312M
| $519K | ﹤0.01% |
+77,269
| New | +$609K |
2026 Q2
0 quarters
|
|
2482
SMJ International Holdings
SMJF
$45.7M
| $517K | ﹤0.01% |
+101,325
| New | +$419K |
2026 Q2
0 quarters
|
|
2483
Hanover Insurance
THG
$8.24B
| $516K | ﹤0.01% |
2,411
-500
| -17% | -$94.7K |
2025 Q4
2 quarters
|
|
2484
Alarum Technologies
ALAR
$10.5M
| $516K | ﹤0.01% |
+64,166
| New | +$500K |
2026 Q2
0 quarters
|
|
2485
Dawson Geophysical
DWSN
$64.6M
| $516K | ﹤0.01% |
86,797
+45,778
| +112% | +$173K |
2026 Q1
1 quarter
|
|
2486
Stagwell
STGW
$2.13B
| $514K | ﹤0.01% |
+69,229
| New | +$459K |
2026 Q2
0 quarters
|
|
2487
Gulfport Energy Corp
GPOR
$2.94B
| $513K | ﹤0.01% |
3,023
-28,002
| -90% | -$5.06M |
2025 Q4
2 quarters
|
|
2488
Ecovyst
ECVT
$1.09B
| $511K | ﹤0.01% |
41,034
+26,334
| +179% | +$357K |
2026 Q1
1 quarter
|
|
2489
Atlantic Union Bankshares
AUB
$5.68B
| $510K | ﹤0.01% |
12,057
+3,799
| +46% | +$145K |
2024 Q4
6 quarters
|
|
2490
CareDx
CDNA
$3.72B
| $510K | ﹤0.01% |
+17,898
| New | +$390K |
2026 Q2
0 quarters
|
|
2491
iShares US Home Construction ETF
ITB
$2.32B
| $507K | ﹤0.01% |
4,856
+3,056
| +170% | +$290K |
2025 Q4
2 quarters
|
|
2492
Genworth Financial
GNW
$3.39B
| $506K | ﹤0.01% |
53,400
+24,700
| +86% | +$220K |
2026 Q1
1 quarter
|
|
2493
KRONOS Worldwide
KRO
$890M
| $503K | ﹤0.01% |
79,479
-15,837
| -17% | -$109K |
2026 Q1
1 quarter
|
|
2494
Sight Sciences
SGHT
$496M
| $503K | ﹤0.01% |
92,819
+23,346
| +34% | +$107K |
2025 Q4
2 quarters
|
|
2495
Safeguard Acquisition Corp
SAC
$317M
| $503K | ﹤0.01% |
50,000
| – | – |
2026 Q1
1 quarter
|
|
2496
Janux Therapeutics
JANX
$1.05B
| $503K | ﹤0.01% |
+32,734
| New | +$474K |
2026 Q2
0 quarters
|
|
2497
NRC Health Common Stock
NRC
$486M
| $502K | ﹤0.01% |
+23,282
| New | +$432K |
2026 Q2
0 quarters
|
|
2498
Mohawk Industries
MHK
$8.46B
| $500K | ﹤0.01% |
4,118
+1,988
| +93% | +$209K |
2026 Q1
1 quarter
|
|
2499
Parke Bancorp
PKBK
$390M
| $499K | ﹤0.01% |
15,062
+7,173
| +91% | +$220K |
2026 Q1
1 quarter
|
|
2500
CoinShares PLC
CSHR
$531M
| $498K | ﹤0.01% |
+132,055
| New | +$695K |
2026 Q2
0 quarters
|
|
Similar funds
Marshall Wace's Q2 2026 Portfolio in Review
As of Q2 2026, Marshall Wace held 3,898 positions worth $127B, up 26% from $100B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Marshall Wace deployed $9.28B of net new capital in Q2 2026, opening 771 new positions and adding to 1,083 existing holdings. Its largest new stake was LPL Financial: 975,627 shares worth $275M.
By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 30% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $1.03B trimmed.
- Marshall Wace's largest Q2 2026 buy was LPL Financial: 975,627 shares worth $275M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.9B increase.
- Marshall Wace's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $1.03B.
- Marshall Wace fully exited Merck in Q2 2026, selling an estimated $325M.
- Marshall Wace's ten largest holdings make up 38% of its $127B portfolio in Q2 2026.
- Marshall Wace opened 771 new positions and closed 795 in Q2 2026.
- Marshall Wace's portfolio value rose 26% quarter-over-quarter to $127B.
Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.